Whitney J Goede1, Jenna K Lovely1, Rodney L Thompson2, Robert R Cima3. 1. Pharmacy Services. 2. Division of Infectious Diseases. 3. Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota. Corresponding author: Jenna K. Lovely, PharmD, Pharmacy Services, Mayo Clinic, 200 First Street SW, Rochester MN 55905; e-mail: lovely.jenna@mayo.edu .
Abstract
BACKGROUND: Surgical site infections (SSIs) are the leading cause of hospital-acquired infections and are associated with substantial health care costs, with increased morbidity and death. The Surgical Care Improvement Project (SCIP) contains standards that are nationally reported with the aim of improving patient outcomes after surgery. Our institution's standards for antimicrobial prophylaxis in the perioperative period are more stringent than these measures and may be considered "beyond SCIP." The 4 elements of appropriate antimicrobial prophylaxis are timing, antibiotic selection, dosing, and intraoperative redosing. OBJECTIVE: To quantify antimicrobial SSI prophylaxis compliance in accordance with institutional standards and to identify potential opportunities for improvement. METHODS: Patients aged 18 years or older were included if they had an SSI between January 1, 2009, and June 30, 2010, according to the database maintained prospectively by the Infection Prevention and Control Unit. Adherence to our institution's practice standards was assessed through analysis of antibiotics administered-timing in relation to the incision, closure, and tourniquet inflation times for the procedure and antibiotic selection, dose, and redosing. RESULTS: Overall noncompliance with all 4 elements of antimicrobial prophylaxis was 75.4% among the 760 cases. Repeat dosing had the greatest noncompliance (45.1%); antibiotic selection had the lowest incidence of noncompliance (10.8%). CONCLUSIONS: Noncompliance existed in each element of antimicrobial SSI prophylaxis, with antibiotic redosing leading in noncompliance. With the implementation of tools to assist the surgical team in following institutional standards, noncompliance will likely decline and additional research opportunities will exist.
BACKGROUND: Surgical site infections (SSIs) are the leading cause of hospital-acquired infections and are associated with substantial health care costs, with increased morbidity and death. The Surgical Care Improvement Project (SCIP) contains standards that are nationally reported with the aim of improving patient outcomes after surgery. Our institution's standards for antimicrobial prophylaxis in the perioperative period are more stringent than these measures and may be considered "beyond SCIP." The 4 elements of appropriate antimicrobial prophylaxis are timing, antibiotic selection, dosing, and intraoperative redosing. OBJECTIVE: To quantify antimicrobial SSI prophylaxis compliance in accordance with institutional standards and to identify potential opportunities for improvement. METHODS:Patients aged 18 years or older were included if they had an SSI between January 1, 2009, and June 30, 2010, according to the database maintained prospectively by the Infection Prevention and Control Unit. Adherence to our institution's practice standards was assessed through analysis of antibiotics administered-timing in relation to the incision, closure, and tourniquet inflation times for the procedure and antibiotic selection, dose, and redosing. RESULTS: Overall noncompliance with all 4 elements of antimicrobial prophylaxis was 75.4% among the 760 cases. Repeat dosing had the greatest noncompliance (45.1%); antibiotic selection had the lowest incidence of noncompliance (10.8%). CONCLUSIONS: Noncompliance existed in each element of antimicrobial SSI prophylaxis, with antibiotic redosing leading in noncompliance. With the implementation of tools to assist the surgical team in following institutional standards, noncompliance will likely decline and additional research opportunities will exist.
Authors: Erin Koopman; David E Nix; Brian L Erstad; Michael J Demeure; Melinda M Hayes; John T Ruth; Kathryn R Matthias Journal: Am J Health Syst Pharm Date: 2007-09-15 Impact factor: 2.637
Authors: E P Dellinger; P A Gross; T L Barrett; P J Krause; W J Martone; J E McGowan; R L Sweet; R P Wenzel Journal: Clin Infect Dis Date: 1994-03 Impact factor: 9.079
Authors: Eli N Perencevich; Kenneth E Sands; Sara E Cosgrove; Edward Guadagnoli; Ellen Meara; Richard Platt Journal: Emerg Infect Dis Date: 2003-02 Impact factor: 6.883
Authors: Daniela Bertschi; Walter P Weber; Jasmin Zeindler; Daniel Stekhoven; Robert Mechera; Lilian Salm; Marco Kralijevic; Savas D Soysal; Marco von Strauss; Edin Mujagic; Walter R Marti Journal: World J Surg Date: 2019-10 Impact factor: 3.352
Authors: Massimo Sartelli; Therese M Duane; Fausto Catena; Jeffrey M Tessier; Federico Coccolini; Lillian S Kao; Belinda De Simone; Francesco M Labricciosa; Addison K May; Luca Ansaloni; John E Mazuski Journal: Surg Infect (Larchmt) Date: 2016-11-09 Impact factor: 2.150
Authors: Zachary M Dong; Alexis P Chidi; Julie Goswami; Katrina Han; Richard L Simmons; Matthew R Rosengart; Allan Tsung Journal: HPB (Oxford) Date: 2015-09-03 Impact factor: 3.647